Construction and Comprehensive Analysis of a Competitive Endogenous RNA Network and Potential Regulatory Axes in Gastric Cancer

Hongda Pan,Jingxin Pan,Dongwei Guo,Shibo Song,Yibin Guo,Dazhi Xu
DOI: https://doi.org/10.2139/ssrn.3369753
2019-01-01
SSRN Electronic Journal
Abstract:Background: Long non-coding RNAs (lncRNAs) have been identified as micro RNA (miRNA) sponges in a competing endogenous RNA (ceRNA) network, and are involved in the regulation of gene expression. This study aims to construct a lncRNA-associated ceRNA network in GC. Methods: Differentially expressed lncRNAs, mRNAs, and miRNAs were identified by analyzing the expression profiles of GC retrieved from The Cancer Genome Atlas (TCGA) database. The lncRNA-miRNA-mRNA regulatory networks of GC were constructed by comprehensive bioinformatics methods including functional annotation, RNA-RNA interactomes prediction, correlation analysis, and survival analysis. The interactions and correlations among ceRNAs were validated by experiments on cancer tissues and cell lines. Results: A total of 41 lncRNAs, 9 miRNAs, and 10 mRNAs were identified and selected to establish the ceRNA regulatory network of GC. Several ceRNA regulatory axes, which consist of 18 lncRNAs, 4 miRNAs, and 6 mRNAs, were obtained from the network. A potential ADAMTS9-AS2/miR-372/CADM2 axis which perfectly conformed to the ceRNA theory was further analyzed. qRT-PCR revealed that ADAMTS9-AS2 knockdown significantly increased miR-372 expression but reduced CADM2 expression, while ADAMTS9-AS2 overexpression had the opposite effects. Dual luciferase reporter assay indicated that miR-372 could bound to the ADAMTS9-AS2 and the 3'UTR of CADM2. Conclusions: The constructed novel ceRNA network and the potential regulatory axes might provide a comprehensive understanding of the potential mechanisms of development in GC. The ADAMTS9-AS2/miR-372/CADM2 axis could serve as a potential therapeutic target for GC treatment.Funding Statement: This study was supported by Beijing Natural Science Foundation (7184240). Declaration of Interests: The authors declare: "None."Ethics Approval Statement: Written informed consent was obtained from all patients. This study was performed with the approval of the Ethics Committee of the Beijing Hospital.
What problem does this paper attempt to address?